drug

Active rTMS stimulation

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by The University of Texas Health Science Center, Houston
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DEVICE

Indications

Trials

2
Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia
NCT07060066—Recruiting
Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment
NCT02916810—Recruiting

KOLs & investigators

1
Xiaoming Du, PhDKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
The University of Texas Health Science Center, Houston
company
trial
Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia
NA
trial
Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment
NA
trial
indication
Schizophrenia
indication
Depression
indication
Schizophrenia and Related Disorders
indication
KOL
Xiaoming Du, PhD
KOL score 5
person